Allspring Global Investments Holdings, LLC Anavex Life Sciences Corp. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.2 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023
BUY
$6.55 - $9.37 $20,049 - $28,681
3,061 New
3,061 $20,000
Q2 2023

Jul 18, 2023
BUY
$7.66 - $9.5 $15,817 - $19,617
2,065 New
2,065 $16,000
Q2 2022

Jul 25, 2022
SELL
$7.31 - $12.84 $115,761 - $203,334
-15,836 Reduced 89.23%
1,911 $19,000
Q1 2022

May 02, 2022
BUY
$9.74 - $17.69 $2,055 - $3,732
211 Added 1.2%
17,747 $218,000
Q4 2021

Jan 28, 2022
BUY
$16.88 - $23.31 $296,007 - $408,764
17,536 New
17,536 $304,000

Others Institutions Holding AVXL

# of Institutions
159
Shares Held
31.6M
Call Options Held
910K
Put Options Held
1.35M
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $352M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email